GS
BMY icon

GTS Securities’s Bristol-Myers Squibb BMY Stock Holding History

GTS Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,135
Closed -$372K – 1387
2026
Q1 		$372K Sell
6,135
-13,152
-68% -$767K 0.01% 954
2025
Q4 		$1.04M Buy
19,287
+11,042
+134% +$531K 0.04% 431
2025
Q3 		$372K Sell
8,245
-7,068
-46% -$330K 0.01% 905
2025
Q2 		$709K Sell
15,313
-18,644
-55% -$915K 0.03% 504
2025
Q1 		$2.07M Buy
33,957
+14,046
+71% +$819K 0.09% 170
2024
Q4 		$1.13M Sell
19,911
-152,846
-88% -$8.54M 0.05% 303
2024
Q3 		$8.94M Sell
172,757
-123,325
-42% -$5.79M 0.02% 558
2024
Q2 		$12.3M Buy
296,082
+103,781
+54% +$4.64M 0.03% 418
2024
Q1 		$10.4M Sell
192,301
-70,279
-27% -$3.58M 0.02% 490
2023
Q4 		$13.5M Buy
262,580
+154,833
+144% +$8.13M 0.02% 484
2023
Q3 		$6.25M Buy
107,747
+65,881
+157% +$4.04M 0.01% 813
2023
Q2 		$2.68M Buy
+41,866
New +$2.81M 0.08% 223

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GTS Securities's BMY Position: Q2 2026 in Review

GTS Securities sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 6,135 shares — an estimated $372K sold.

GTS Securities first reported a position in BMY in Q2 2023 and held it in 12 quarters. The position peaked at $13.5M in Q4 2023. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • GTS Securities reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 6,135 Bristol-Myers Squibb shares in Q2 2026, an estimated $372K.
  • GTS Securities first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 12 quarters.
  • GTS Securities's Bristol-Myers Squibb position peaked at $13.5M in Q4 2023.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.